ACB Stock: "Aurora Cannabis: Record Profits, No MedLeaf Deal!" скачать в хорошем качестве

ACB Stock: "Aurora Cannabis: Record Profits, No MedLeaf Deal!"

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the fourth quarter and fiscal year 2025 periods ending March 31, 2025. "We are pleased to report an exceptional year to our shareholders, highlighted by record annual global medical net revenue1, adjusted EBITDA1, and positive free cash flow1. These achievements underscore the thoughtful execution of our strategic plan, set us further apart from competitors, and strengthen our foundation for sustained and profitable growth," said Executive Chairman and Chief Executive Officer for Aurora, Miguel Martin. Aurora Cannabis (ACB) said late Wednesday it has not agreed to acquire New Zealand's MedLeaf Therapeutics, denying an online report claiming otherwise. The company said the information, posted on a news website, is false, and it has not held any discussions with MedLeaf regarding a business combination and has made no statements or filings suggesting such a deal. Is ACB a buy or sell? What is the target price for ACB stock? Is ACB being shorted? What was the highest price for ACB stock? tilray stock, acb stockhouse, acb stock split, acb stock forecast. should i sell my acb stock now? acb stock forum, acb stock news. acb stock buy or sell?